The July update of the Ambulatory Surgical Center Payment System (ASC PS) implements several changes to Medicare billing instructions of which ASC coding and billing staff should be aware. The update includes new Category III codes, new instructions for device pass-through category C1840, and billing changes for medication. Billing staff, in particular, should take note of payment indicator changes for certain drug supply codes as claims adjustments may be necessary. (more…)
June 1st, 2012
The Centers for Medicare & Medicaid Services (CMS) have made several changes to the HCPCS Level II code set, revising two codes and adding several more, effective July 1.
Two codes now covered by carrier discretion will no longer be covered:
J1680 Injection, human fibrinogen concentrate, 100 mg
J9001 Injection, doxorubicin HCl, all lipid formulations, 10 mg
The following codes are being added, with coverage left to carrier discretion:
Q2034 Influenza virus vaccine, split virus, for intramuscular use (Agriflu)
Q2045 Human fibrinogen concentrate, 1 mg
Q2046 Injection, aflibercept, 1 mg
Q2047 Injection, peginesatide, 0.1 mg (for ESRD on dialysis)
Q2048 Injection, doxorubicin hydrochloride, liposomal imported lipodox, 10 mg
Q2049 Injection, doxorubicin hydrochoride, liposomal, imported lipodox, 10 mg
One new code will not be covered by Medicare:
S1090 Mometasone furoate sinus implant, 370 micrograms
April 9th, 2012